An international group of researchers working with Erasmus University Medical Center (Erasmus MC) in the Netherlands determined that SkinVision—the first CE-marked skin cancer application based on extensive clinical trials—has a sensitivity of 95.1% in detecting the most common forms of skin cancer. The research published in the Journal of the European Academy of Dermatology and […]